IP Library › Granted Patent US 9,744,231
Granted Patent B2
US 9,744,231 · App. 14/011,258 · Granted Aug 29, 2017

Quality control methods for oil-in-water emulsions containing squalene

Inventor: Norbert Klein (Cambridge, MA)
Assignee: NOVARTIS AG
A61K39/39A61K9/10A61K39/145A61K47/26A61K2039/55566Y10T436/216
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,744,231
App. No.
14/011,258
Granted
Aug 29, 2017
Kind
B2
Abstract

Measurements of the squalene content in oil-in-water emulsions can be used as a way of checking for problems during production. In particular, it has been found that a drop in squalene content can indicate that filtration problems occurred. Testing the squalene content in the final lots is easier than investigating the characteristics of the filter, and so a squalene assay simplifies the quality control of oil-in-water emulsions.

Claims (16)

1. A method for controlling the quality of an oil-in-water emulsion adjuvant, which comprises squalene and an aqueous carrier as components, by determining whether said oil-in-water adjuvant has an acceptable level of squalene, said method comprises:

preparing the oil-in-water emulsion by placing the components of the oil-in-water emulsion in a microfluidizer and microfluidizing the components to form a microfluidized mixture;

(ii) filtering the microfluidized mixture through a filter to provide the oil-in-water emulsion and forming the oil-in-water adjuvant;

(iii) measuring the actual squalene content in said oil-in-water emulsion adjuvant;

(iv) comparing the actual squalene content in said oil-in-water emulsion adjuvant with a standard squalene content;

(v) rejecting said oil-in-water emulsion adjuvant if the actual squalene content of said oil-in-water emulsion adjuvant differs from the standard squalene content by more than plus or minus 10%.

2. The method according to claim 1 , wherein the components of the oil-in-water emulsion further comprise a surfactant.

3. The method according to claim 1 wherein the oil-in-water emulsion in the oil-in-water adjuvant is a submicron emulsion.

4. The method according to claim 3 , wherein the components of oil-in-water emulsion adjuvant further comprise polyoxyethylenesorbitan monooleate and sorbitan trioleate.

5. The method according to claim 1 , wherein the components of the oil-in water emulsion further comprises a tocopherol and polyoxyethylenesorbitan monooleate.

6. The method of claim 1 , wherein the components of the emulsion in the oil-in water emulsion further comprises a tocopherol and t-octylphenoxypolyethoxyethanol.

7. The method of claim 1 , wherein the components of the oil-in water emulsion further comprises a polyoxyethylene alkyl ether hydrophilic nonionic surfactant and a hydrophobic nonionic surfactant.

8. The method of claim 1 , wherein if the oil-in-water emulsion adjuvant has an acceptable level of squalene content, the method further comprises the further step of (v) combining the oil-in-water adjuvant with an antigen.

9. The method of claim 8 , wherein the antigen is an influenza antigen.

10. The method of claim 1 , wherein the standard squalene content is a squalene concentration between 2% and 8% by volume.

11. The method of claim 10 , wherein the standard squalene content is a squalene concentration between 4% and 6% by volume.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2024
From: NOVARTIS AG
To: SEQIRUS UK LIMITED
Reel/Frame 069642/0293 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2017
From: KLEIN, NORBERT
To: NOVARTIS VACCINES AND DIAGNOSTICS GMBH & CO. KG
Reel/Frame 042486/0638 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2017
From: NOVARTIS VACCINES AND DIAGNOSTICS GMBH & CO. KG
To: NOVARTIS AG
Reel/Frame 042486/0669 →
Priority Claims (1)
GB 06222822 · Nov 8, 2006 · national
Continuity (2)
Continuation 12312629
Related Publication 20140178428A1 · Jun 26, 2014